Innovation

For Australian investors and founders, the big questions are which parts of biotech are becoming repeatable businesses, and which parts remain experimental theatre, writes Anthony Liveris.

From an intelligent ‘longevity mirror’ to Boston Dynamics’ Atlas Robot, CES is the place to be to see the next round of cutting-edge technology. Dr Catherine Ball’s boots were on the ground in Las Vegas.

An ‘orchestrator’ or ‘fixer’ of AI owns a company’s internal AI operating layer – deciding where AI should live, how it should be used, writes Annie Liao.

SXSW Sydney, the Australian extension of the iconic tech, music and film conference born out of Austin, Texas, will not return for 2026.

Y Combinator is leading the round, backed by Australia’s NextGen Ventures, Antler and Meat & Livestock Australia, as GrazeMate expands from Queensland and NSW into California.

The British communications agency said it “urgently made contact with X” to determine its compliance with the country’s Online Safety Act over sexual imagery, and a ban is on the table

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

Advancements in machine learning and other technologies have helped Seeing Machines develop new safety solutions for drivers, including intoxication detection, 3D cabin perception mapping, and a new rear-view mirror solution.

Depending on who you ask, 2024 was the year of chatbots, then 2025 was the year of agents. 

From Trump frenemyship, the DOGE debacle, unmet self-driving car promises, chainsaws and “Mechahitler” to a $1 trillion pay deal, 2025 was the billionaire’s most chaotic and lucrative year.